1.26.2019 Issue 156

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Sr. Director, Health Economics
and Outcomes Research

The Sr. Director of Global HEOR will play a critical and significant role in the growth of Akcea as an organization and in the successful commercialization of Waylivra™ (volanesorsen), Tegsedi™ (inotersen) and our pipeline products.

Health Economics Analyst / Statistician

Health Economics Consultant

Health Economics Engagement Manager

Healthcare Data Scientist

Sr. Director, Health Economics and Outcomes Research

Director, Statistics - Real-World Evidence (Flexible Location)

Managing Consultant – Market Access Consulting (Waltham, MA)

Executive Director, Integrated Solutions - Real-World Evidence (Flexible Location)

HealthCore-NERI’s Singer Talks RWE, Pragmatic Clinical Trials

Pharmerit Expands Market Access Support in Asia

NorthShore, Color Partner to Implement Genomic Data for 10K Patients

United Healthcare Sues Pharma Companies

Industry Spotlight

Conferences Webinars
The Payer and Provider Ecosystem Evolution
    January 27-30, San Diego, California

The Role of Real-World Evidence in Regulatory and Value-Based Payment Decision-making
    January 28, Washington, D.C.

2nd Annual Provider Strategies on Community Partnerships and Social Determinants of Health Track
    January 30-February 1, Atlanta, Georgia

Statistical Learning: What Is It? How Does It Relate to Machine Learning and AI? How is It Applied in Healthcare?
    January 30

Let’s Get Real: How Will the FDA Framework for Real-World Evidence Impact You?
    January 30

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)

From Patent to Patient: Analyzing Access to Innovative Cancer Drugs

Transitioning Payment Models: Fee-for-Service to Value-Based Care

Special Thanks to Our Partners:
               Evidera   HealthCore  
      University of FL   Xcenda  OM1    Parexel   Jefferson
      Dymaxium   Precision Xtract    Pharmerit    eMax Health
      Sciformix   Evidence Partners    ICON    Truven